Coordinating and Data Management Center for Acquired Resistance to Therapy Network

获得性治疗耐药网络协调和数据管理中心

• 批准号: 10516537
• 负责人: DAVID W. GOODRICH
• 金额: $ 105.04万
• 依托单位: ROSWELL PARK CANCER INSTITUTE CORP
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-09-01 至 2027-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10516537
• 关键词: Address; Adopted; Bioconductor; Bioinformatics; Biometry; Biostatistics Shared Resource; Cancer Center Support Grant; Clinical; Collaborations; Combined Modality Therapy; Communities; Comprehension; Computer software; Custom; Data; Data Management Resources; Data Science; Data Set; Data Storage and Retrieval; Databases; Development; Drug Kinetics; Drug resistance; Ecosystem; Ensure; Fostering; Funding; Goals; Hand; Immunooncology; Immunotherapy; Informatics; Information Technology; Infrastructure; Lead; Malignant Neoplasms; Methods; Multiomic Data; National Human Genome Research Institute; Patients; Pharmacodynamics; Police; Policies; Principal Investigator; Productivity; PubMed; Records; Reproducibility; Research; Research Personnel; Research Project Grants; Resistance; Resource Sharing; Resources; Services; Text; Therapeutic; Translating; United States National Institutes of Health; Visualization; base; biobank; biomedical informatics; cancer therapy; cloud based; community engagement; cost; data acquisition; data ecosystem; data harmonization; data integration; data management; data repository; data resource; data sharing; data sharing networks; data standards; drug sensitivity; experience; genomic data; improved; interoperability; multidisciplinary; open source; operation; outreach; pharmacokinetics and pharmacodynamics; pre-clinical; predictive marker; quality assurance; real time monitoring; repository; resistance mechanism; response; support network; therapy resistant; tool; translational oncology; tumor microenvironment; virtual

Project Summary The goal of our proposed Coordinating and Data Management Center (CDMC) application is to coordinate the activities across the Acquired Resistance to Therapy Network (ARTNet), and to manage, integrate and disseminate the data and resources generated through the network. Leveraging cutting-edge multi-disciplinary team approaches, we will support the ARTNet to inform new strategies that can be better translated to overcome significant challenges in acquired resistance to cancer therapies. Our strategy is to enhance the productivity of ARTNet investigators by fostering a collaborative and supportive research community, accelerate the progress of ARTNet research by reducing barriers to accessing analytical expertise, ensure the reproducibility of ARTNet data by deploying best practices for data acquisition and harmonization, and unleash the full potential of ARTNet activities by developing enhanced tools to enable resource sharing to the broader scientific community. First, we will provide a centralized administrative infrastructure to coordinate ARTNet activities, building upon our well-functioning infrastructure that currently coordinates network studies under the umbrella of the NCI Cancer Moonshot initiatives. Second, we will actively promote the ARTNet and engage in trans-consortium interactions, where we will leverage our demonstrable experience in Cross-Moonshot outreach and Bioconductor’s decades-long record in community engagement. Third, we will provide multidisciplinary analytical expertise to support ARTNet collaborative research, leveraging five of Roswell Park CCSG’s shared resources: Biostatistics, Bioinformatics, Biomedical Informatics, Pharmacokinetics/Pharmacodynamics, and Data Bank and BioRepository. Our analytical support will be provided at no cost to ARTNet investigators in need of analytical expertise, based on collaboration, transparency, and sharing. Fourth, we will develop improved data integration software and workflows to enhance ARTNet’s research capacity, capitalizing on our extensive track-record in developing NIH-supported Moonshot, Bioconductor and AnVIL ecosystems. The main deliverables from the proposed aims will be administrative and outreach support to coordinate network activities, facilitate network collaboration, and engage in interaction with the broader community (Aim 1); polices and infrastructures to ensure that all resources generated by the ARTNet will be findable in a centralized virtual resource sharing repository, and that all resources will be shared with the broader scientific community (Aim 2); workflows to ensure that all data generated by the ARTNet will be harmonized using standards interoperable with the broader cancer data ecosystem, analysis tools to integrate ARTNet data and facilitate cross-study analysis within and beyond the ARTNet, and multidisciplinary analytical supports to accelerate ARTNet research progress.(Aim 3).

项目摘要 我们建议的协调和数据管理中心(CDMC)应用程序的目标是协调 通过获得性抵抗治疗网络(ARTnet)开展活动，并管理、集成和 通过网络传播产生的数据和资源。利用尖端的多学科 团队方法，我们将支持Artnet通知新的战略，这些战略可以更好地转化为克服 癌症治疗获得性耐药方面的重大挑战。我们的战略是提高 Artnet调查人员通过培育协作和支持的研究社区，加快进度 通过减少获取分析专业知识的障碍，确保Artnet研究的重现性 通过部署数据获取和协调的最佳做法，并充分释放Artnet的潜力 通过开发增强的工具，使更广泛的科学界能够共享资源，开展各种活动。 首先，我们将提供一个集中的管理基础设施来协调Artnet活动，在此基础上 我们运行良好的基础设施，目前在NCI的保护伞下协调网络研究 癌症登月计划。第二，积极推进ARTNet，开展跨联合体 互动，我们将利用我们在跨月球拍摄方面的明显经验和 生物导体数十年来在社区参与方面的记录。第三，我们将提供多学科分析 支持Artnet协作研究的专业知识，利用Roswell Park CCSG的五个共享资源： 生物统计学、生物信息学、生物医学信息学、药代动力学/药效学、数据库和 生物储存库。我们的分析支持将免费提供给需要分析的Artnet调查人员 基于协作、透明和共享的专业知识。四是加强数据融合 软件和工作流程，以增强Artnet的研究能力，充分利用我们在 开发由美国国立卫生研究院支持的登月、生物导体和铁锤生态系统。 拟议目标的主要交付成果将是行政和外联支助，以协调 网络活动，促进网络协作，并与更广泛的社区进行互动(AIM 1)；政策和基础设施，以确保Artnet生成的所有资源都可以在 集中的虚拟资源共享库，所有资源都将与更广泛的科学领域共享 社区(目标2)；确保Artnet生成的所有数据将使用以下工具进行协调的工作流程 可与更广泛的癌症数据生态系统互操作的标准、集成Artnet数据和 促进Artnet内外的交叉研究分析，并提供多学科分析支持以 加快Artnet研究进展。(目标3)。